172 related articles for article (PubMed ID: 10632743)
1. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
Wong WY; Huang WC; Miller R; McGinty K; Whisnant JK
Haemophilia; 2000 Jan; 6(1):50-4. PubMed ID: 10632743
[TBL] [Abstract][Full Text] [Related]
2. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Karimi M
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
[No Abstract] [Full Text] [Related]
5. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
Scharrer I
Haemophilia; 1999 Jul; 5(4):253-9. PubMed ID: 10469179
[TBL] [Abstract][Full Text] [Related]
6. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Mariani G; Konkle BA; Ingerslev J
Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
[TBL] [Abstract][Full Text] [Related]
7. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
8. A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
Faranoush M; Abolghasemi H; Toogeh G; Karimi M; Eshghi P; Managhchi M; Hoorfar H; Dehdezi BK; Mehrvar A; Khoeiny B; Kamyar K; Heshmat R; Baghaeipour MR; Mirbehbahani NB; Fayazfar R; Ahmadinejad M; Naderi M
Clin Appl Thromb Hemost; 2015 Nov; 21(8):724-8. PubMed ID: 24651301
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
[TBL] [Abstract][Full Text] [Related]
10. Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.
Désage S; Chamouard V; Meunier S; Enjolras N; Sobas F; Négrier C; Le Quellec S
Haemophilia; 2021 Jul; 27(4):e487-e490. PubMed ID: 33215792
[No Abstract] [Full Text] [Related]
11. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
[TBL] [Abstract][Full Text] [Related]
12. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.
White B; O'Connor H; Smith OP
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):155-7. PubMed ID: 10759008
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
[TBL] [Abstract][Full Text] [Related]
14. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy in women with congenital factor VII deficiency.
Kulkarni AA; Lee CA; Kadir RA
Haemophilia; 2006 Jul; 12(4):413-6. PubMed ID: 16834743
[TBL] [Abstract][Full Text] [Related]
17. A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
Sun Y; Jia L; Yang Z; Chen W
Medicine (Baltimore); 2018 Nov; 97(44):e12776. PubMed ID: 30383632
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII as a universal haemostatic agent.
Hedner U
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
[TBL] [Abstract][Full Text] [Related]
19. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
[TBL] [Abstract][Full Text] [Related]
20. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
